Literature DB >> 8590999

Specificity of different organic nitrates to elicit NO formation in rabbit vascular tissues and organs in vivo.

A Mülsch1, A Bara, P Mordvintcev, A Vanin, R Busse.   

Abstract

1. In the present study we assessed the formation of nitric oxide (NO) from classical and thiol-containing organic nitrates in vascular tissues and organs of anaesthetized rabbits, and established a relationship between the relaxant response elicited by nitroglycerin (NTG) and NO formation in the rabbit isolated aorta. Furthermore, the effect of isolated cytochrome P450 on NO formation from organic nitrates was investigated. 2. Rabbits received diethyldithiocarbamate (DETC; 200 mg kg-1 initial bolus i.p. and 200 mg kg-1 during 20 min, i.v.) and either saline, or one of the following organic nitrates: nitroglycerin (NTG, 0.5 mg kg-1), isosorbide dinitrate (ISDN), N-(3-nitratopivaloyl)-L-cysteine ethylester (SPM 3672), S-carboxyethyl-N-(3-nitratopivaloyl)-L-cysteine ethylester (SPM 5185), at 10 mg kg-1 each. After 20 min the animals were killed, blood vessels and organs were removed, and subsequently analyzed for spin-trapped NO by cryogenic electron spin resonance (e.s.r.) spectroscopy. 3. In the saline-treated control group, NO remained below the detection limit in all vessels and organs. In contrast, all of the nitrates tested elicited measurable NO formation, which was higher in organs (liver, kidney, heart, lung, spleen) (up to 4.8 nmol g-1 20 min-1) than in blood vessels (vena cava, mesenteric bed, femoral artery, aorta) (up to 0.7 nmol g-1 20 min-1). Classical organic nitrates (NTG, ISDN) formed NO preferentially in the mesenteric bed and the vena cava, while the SPM compounds elicited comparable NO formation in veins and arteries. 4. Using a similar spin trapping technique, NO formation was assessed in vitro in phenylephrine-precontracted rabbit aortic rings. The maximal relaxation elicited by a first exposure (10 min) to NTG (0.3 to 10 microM) was positively correlated (r = 0.8) with the net increase (NTG minus basal) of NO spin-trapped during a second exposure to the same concentration of NTG in the presence of DETC. 5. Cytochrome P450 purified from rabbit liver enhanced NO formation in a NADPH-dependent fashion from NTG, but not from the other nitrates, as assessed by activation of purified soluble guanylyl cyclase. 6. We conclude that the vessel selective action of different organic nitrates in vivo reflects differences in vascular NO formation. Thus, efficient preload reduction by classical organic nitrates can be accounted for by higher NO formation in venous capacitance as compared to arterial conductance and resistance vessels. In contrast, NO is released from cysteine-containing nitrates (SPMs) to a similar extent in arteries and veins, presumably independently of an organic nitrate-specific biotransformation. Limited tissue bioavailability of NTG and ISDN might account for low NO formation in the aorta, while true differences in biotransformation seem to account for differences in NO formation in the other vascular tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590999      PMCID: PMC1909127          DOI: 10.1111/j.1476-5381.1995.tb17236.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Purification of heme-containing soluble guanylyl cyclase.

Authors:  A Mülsch; R Gerzer
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  On-line measurement of nitric oxide release from organic nitrates in the intact coronary circulation.

Authors:  K Schrör; S Förster; I Woditsch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-08       Impact factor: 3.000

Review 3.  Organic nitrate esters: clinical use and mechanisms of actions.

Authors:  J Ahlner; R G Andersson; K Torfgård; K L Axelsson
Journal:  Pharmacol Rev       Date:  1991-09       Impact factor: 25.468

4.  Enzymic and nonenzymic release of NO accounts for the vasodilator activity of the metabolites of CAS 936, a novel long-acting sydnonimine derivative.

Authors:  A Mülsch; M Hecker; P I Mordvintcev; A F Vanin; R Busse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-01       Impact factor: 3.000

5.  Cytochrome P-450 mediates bioactivation of organic nitrates.

Authors:  H Schröder
Journal:  J Pharmacol Exp Ther       Date:  1992-07       Impact factor: 4.030

6.  Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle and endothelial cells.

Authors:  M Feelisch; M Kelm
Journal:  Biochem Biophys Res Commun       Date:  1991-10-15       Impact factor: 3.575

7.  Biotransformation of glyceryl trinitrate by rat aortic cytochrome P450.

Authors:  B J McDonald; B M Bennett
Journal:  Biochem Pharmacol       Date:  1993-01-07       Impact factor: 5.858

8.  Inhibition of nitrovasodilator- and acetylcholine-induced relaxation and cyclic GMP accumulation by the cytochrome P-450 substrate, 7-ethoxyresorufin.

Authors:  B M Bennett; B J McDonald; R Nigam; P G Long; W C Simon
Journal:  Can J Physiol Pharmacol       Date:  1992-09       Impact factor: 2.273

9.  Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin.

Authors:  M A Kurz; K G Lamping; J N Bates; C L Eastham; M L Marcus; D G Harrison
Journal:  Circ Res       Date:  1991-03       Impact factor: 17.367

10.  Inhibitors of cytochrome P-450 reduce cyclic GMP stimulation by glyceryl trinitrate in LLC-PK1 kidney epithelial cells.

Authors:  H Schröder; K Schrör
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-11       Impact factor: 3.000

View more
  11 in total

Review 1.  Nitrates and nitrites in the treatment of ischemic cardiac disease.

Authors:  Vaughn E Nossaman; Bobby D Nossaman; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Jul-Aug       Impact factor: 2.644

Review 2.  NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.

Authors:  Oleg V Evgenov; Pál Pacher; Peter M Schmidt; György Haskó; Harald H H W Schmidt; Johannes-Peter Stasch
Journal:  Nat Rev Drug Discov       Date:  2006-09       Impact factor: 84.694

3.  Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice.

Authors:  P Wenzel; U Hink; M Oelze; A Seeling; T Isse; K Bruns; L Steinhoff; M Brandt; A L Kleschyov; E Schulz; K Lange; H Weiner; J Lehmann; K J Lackner; T Kawamoto; T Münzel; A Daiber
Journal:  Br J Pharmacol       Date:  2007-01-15       Impact factor: 8.739

4.  S-Nitrosated Polypropylene Sulfide Nanoparticles for Thiol-Dependent Transnitrosation and Toxicity Against Adult Female Filarial Worms.

Authors:  Alex Schudel; Timothy Kassis; J Brandon Dixon; Susan N Thomas
Journal:  Adv Healthc Mater       Date:  2015-05-04       Impact factor: 9.933

Review 5.  The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics.

Authors:  Sanjay Divakaran; Joseph Loscalzo
Journal:  J Am Coll Cardiol       Date:  2017-11-07       Impact factor: 24.094

6.  Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy.

Authors:  Ken-ichiro Sasaki; Christopher Heeschen; Alexandra Aicher; Thomas Ziebart; Joerg Honold; Carmen Urbich; Lothar Rossig; Ulrike Koehl; Masamichi Koyanagi; Annisuddin Mohamed; Ralf P Brandes; Hans Martin; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

7.  Mechanisms of nitric oxide generation from nitroglycerin and endogenous sources during hypoxia in vivo.

Authors:  Per Agvald; L Christofer Adding; Andreas Artlich; Magnus G Persson; Lars E Gustafsson
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

8.  Differential nitros(yl)ation of blood and tissue constituents during glyceryl trinitrate biotransformation in vivo.

Authors:  David R Janero; Nathan S Bryan; Fumito Saijo; Vijay Dhawan; David J Schwalb; Michael C Warren; Martin Feelisch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-18       Impact factor: 11.205

Review 9.  Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress.

Authors:  Andreas Daiber; Thomas Münzel
Journal:  Antioxid Redox Signal       Date:  2015-09-24       Impact factor: 8.401

Review 10.  New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance.

Authors:  A Daiber; P Wenzel; M Oelze; T Münzel
Journal:  Clin Res Cardiol       Date:  2007-10-19       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.